TIGIT and colonic neoplasm: Moreover, animals treated with dual anti-TIGIT/PD-1 antibodies showed increased IFN-γ secretion by CD4+ TILs in the MC38 colon tumor mouse model, compared to single anti-PD-1 treatment (69).